Aliskiren Hemifumarate; Amlodipine Besylate; Hydrochlorothiazide Patent Expiration
Aliskiren Hemifumarate; Amlodipine Besylate; Hydrochlorothiazide is Used for lowering high blood pressure (hypertension). It was first introduced by Novartis Pharmaceuticals Corp
Aliskiren Hemifumarate; Amlodipine Besylate; Hydrochlorothiazide Patents
Given below is the list of patents protecting Aliskiren Hemifumarate; Amlodipine Besylate; Hydrochlorothiazide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Amturnide | US8183295 | Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
May 16, 2023
(Expired) | Novartis |
| Amturnide | US8618174 | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
Nov 15, 2021
(Expired) | Novartis |
| Amturnide | US5559111 | δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
Jul 21, 2018
(Expired) | Novartis |
Aliskiren Hemifumarate; Amlodipine Besylate; Hydrochlorothiazide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List